Pharma Intelligence Informatics Solutions, Datamonitor Healt...
Streamline your workflow with a new solution that delivers critical disease overviews back to you quickly, easily, and efficiently with the new Pharma360.
Recent months have seen a remarkable convergence of initiatives to foster greater European cooperation in market access. On the one hand, the EU has been promoting measures to expedite the launch of new medicines (eg adaptive pathways) and facilitate joint activity in health technology assessment. On the other hand, concerns over the pricing of some new drugs – most notably Gilead’s Sovaldi (sofosbuvir) – have prompted national governments to seek new alliances in order to help control the cost of innovative medicines. Whilst international collaboration in market access has undeniable attractions, it’s important to understand the recent changes thoroughly, especially in terms of the challenges such collaborations are likely to present in practice.
Our latest report provides an in-depth analysis into the recent key developments in the pharmaceutical market access environment and today, we are offering you a complimentary extract of this exclusive report.
This sample extract will provide you with an overview of our latest report ‘Key Trends in European Market Access’ which reviews in-depth the key developments in the pharmaceutical market access environment
Datamonitor Healthcare: data analysis and insight
As the COVID-19 pandemic continues, governments worldwide have pinned their hopes on returning to normality on the development of a vaccine. With multiple vaccines currently in late-stage trials, there is promise that a successful vaccine will soon be ready.
Scrip: industry news and insights, Datamonitor Healthcare: d...
In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: